Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore MiNK Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INKT.
You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Burning Rock Biotech (NASDAQ:BNR), Coeptis Therapeutics (NASDAQ:COEP) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
MiNK Therapeutics has a consensus price target of $14.00.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $7.17 last updated May 16, 2025 at 4:01 PM EDT.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.